With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with a transaction set to propel the company into the CDMO market.

Jabil, Inc. engages in the provision of manufacturing services and solutions. It operates through the Electronics Manufacturing Services (EMS) and Diversified Manufacturing Services (DMS) segments.

Jabil saw strength in key end markets lead to quarterly results above its own expectations and that of Wall Street's. The electronics contract manufacturer logged net income of $100 million, or 88 ...